These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 35872300

  • 1. Ototoxicity in childhood: Recommendations of the CODEPEH (Commission for the Early Detection of Childhood Hearing Loss) for prevention and early diagnosis.
    Núñez-Batalla F, Jáudenes-Casaubón C, Sequí-Canet JM, Vivanco-Allende A, Zubicaray-Ugarteche J.
    Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(4):255-265. PubMed ID: 35872300
    [Abstract] [Full Text] [Related]

  • 2. Applications of the Grading Scales for the Detection of Ototoxicity in Children after Treatment of Neuroblastoma and Extracranial Germinal Tumor.
    Polski B, Sosnowska-Sienkiewicz P, Szydłowski J, Januszkiewicz-Lewandowska D.
    Audiol Neurootol; 2023; 28(1):32-42. PubMed ID: 36191558
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.
    Schacht J, Talaska AE, Rybak LP.
    Anat Rec (Hoboken); 2012 Nov; 295(11):1837-50. PubMed ID: 23045231
    [Abstract] [Full Text] [Related]

  • 4. [Drug-induced hearing loss as a manifestation of drug-induced ototoxicity].
    Ostroumova OD, Chikh EV, Rebrova EV, Ryazanova AY, Pereverzev AP.
    Vestn Otorinolaringol; 2019 Nov; 84(4):72-80. PubMed ID: 31579063
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological intervention in the field of ototoxicity.
    Laurell G.
    HNO; 2019 Jun; 67(6):434-439. PubMed ID: 30993373
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of Ototoxicity and Otoprotection.
    Steyger PS.
    Otolaryngol Clin North Am; 2021 Dec; 54(6):1101-1115. PubMed ID: 34774227
    [Abstract] [Full Text] [Related]

  • 7. Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.
    Lanvers-Kaminsky C, Zehnhoff-Dinnesen AA, Parfitt R, Ciarimboli G.
    Clin Pharmacol Ther; 2017 Apr; 101(4):491-500. PubMed ID: 28002638
    [Abstract] [Full Text] [Related]

  • 8. Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
    Fetoni AR, Brigato F, De Corso E, Lucidi D, Sergi B, Scarano E, Galli J, Ruggiero A.
    Eur Arch Otorhinolaryngol; 2022 Oct; 279(10):4677-4686. PubMed ID: 35024956
    [Abstract] [Full Text] [Related]

  • 9. Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.
    Kros CJ, Steyger PS.
    Cold Spring Harb Perspect Med; 2019 Nov 01; 9(11):. PubMed ID: 30559254
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D.
    Ear Hear; 2008 Dec 01; 29(6):875-93. PubMed ID: 18753950
    [Abstract] [Full Text] [Related]

  • 11. Drug-induced hearing loss: Listening to the latest advances.
    Reynard P, Thai-Van H.
    Therapie; 2024 Dec 01; 79(2):283-295. PubMed ID: 37957052
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin and ototoxicity in childhood: the perspective of supporting otoprotective agentes.
    Araujo AGFS, Silva JC, Trindade Filho EM, Silva JC, Gama KDA, Bandeira MAM, Silva WA, Mousinho KC.
    Braz J Biol; 2024 Dec 01; 84():e279117. PubMed ID: 39140499
    [Abstract] [Full Text] [Related]

  • 13. Understanding drug ototoxicity: molecular insights for prevention and clinical management.
    Yorgason JG, Fayad JN, Kalinec F.
    Expert Opin Drug Saf; 2006 May 01; 5(3):383-99. PubMed ID: 16610968
    [Abstract] [Full Text] [Related]

  • 14. N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease.
    Zadrożniak M, Szymański M, Łuszczki JJ.
    Int J Mol Sci; 2023 Apr 20; 24(8):. PubMed ID: 37108758
    [Abstract] [Full Text] [Related]

  • 15. Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.
    Hong H, Dooley KE, Starbird LE, Francis HW, Farley JE.
    Arch Toxicol; 2019 May 20; 93(5):1385-1399. PubMed ID: 30963202
    [Abstract] [Full Text] [Related]

  • 16. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW, van den Berg H, van Dalen EC.
    Cochrane Database Syst Rev; 2014 Jul 01; (7):CD009219. PubMed ID: 24984156
    [Abstract] [Full Text] [Related]

  • 17. Ototoxicity-induced hearing loss and quality of life in survivors of paediatric cancer.
    Rajput K, Edwards L, Brock P, Abiodun A, Simpkin P, Al-Malky G.
    Int J Pediatr Otorhinolaryngol; 2020 Nov 01; 138():110401. PubMed ID: 33152988
    [Abstract] [Full Text] [Related]

  • 18. Ototoxicity.
    Rybak LP, Ramkumar V.
    Kidney Int; 2007 Oct 01; 72(8):931-5. PubMed ID: 17653135
    [Abstract] [Full Text] [Related]

  • 19. Ototoxicity in cancer survivors: Experience and proposal of a surveillance protocol.
    Sánchez-Canteli M, Núñez-Batalla F, Martínez-González P, de Lucio-Delgado A, Antonio Villegas-Rubio J, Gómez-Martínez JR, Luis Llorente-Pendás J.
    An Pediatr (Engl Ed); 2021 Nov 01; 95(5):290-297. PubMed ID: 34702687
    [Abstract] [Full Text] [Related]

  • 20. Ototoxicity monitoring in children treated with platinum chemotherapy.
    Brooks B, Knight K.
    Int J Audiol; 2018 Sep 01; 57(sup4):S34-S40. PubMed ID: 28737048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.